Recent studies indicate that MyD88 in myofibroblasts enhances the development of nonalcoholic fatty liver disease (MASLD)-related liver cancer by promoting M2 macrophage polarization (8). The gene discussed is MYD88; the disease is metabolic dysfunction-associated steatotic liver disease.